Pleuropulmonary Anaerobic Infections

  • Daniel Mathieu
Chapter

Abstract

Anaerobic bacteria are relatively common pulmonary pathogens and involved particularly often in aspiration pneumonia and its suppurative complications: lung abscess and empyema. Although most patients respond well to antibiotic treatment associated to adequate drainage, 5–10% may experience persistent infection. Based on our experience in 13 patients, we propose to consider hyperbaric oxygen (HBO) as an adjunct treatment in highly selected cases

Keywords

Anaerobic bacteria lung abscess empyema necrotizing pneumonia 
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Bartlett JG. Anaerobic bacterial infections of the lung and pleural space. Clin Infect Dis 1993; 16(Suppl): S248–55.PubMedGoogle Scholar
  2. 2.
    Pennza PT. Aspiration pneumonia, necrotizing pneumonia, and lung abscess. Emerg Med Clin North Am 1989; 7: 279–307.PubMedGoogle Scholar
  3. 3.
    Beerens H., Tahon-Castel M. Infections humaines à bactéries anaérobies non toxigènes.Google Scholar
  4. 4.
    Brussels: Presses Académiques Européennes. 1965: 91–114.Google Scholar
  5. 5.
    Bartlett JG., Finegold SM. Anaerobic infections of the lung and pleural space. Am Rev Respir Dis 1974; 110: 56–77.PubMedGoogle Scholar
  6. 6.
    Brook I, Finegold SM. Bacteriology and therapy of lung abscess in children. J Pediatr 1979; 94: 10–2.PubMedCrossRefGoogle Scholar
  7. 7.
    Bartlett JG. Anaerobic bacterial infections of the lung. Chest 1987; 91: 901–9PubMedGoogle Scholar
  8. 8.
    Grinan NP., Lucena FM., Romero JV., Michavila IA., Dominguez SU., Alia CF. Yield of percutaneous needle lung aspiration in lung abscess. Chest 1990; 97: 69–74.Google Scholar
  9. 9.
    Gudiot F., Manresa F., Pallares R. et al. Clindamycin vs. penicillin for anaerobic lung infections: high rate of penicillin failures associated with penicillin-resistant Bacteroides melaninogenicus. Arch Intern Med 1990; 150: 2525–29.CrossRefGoogle Scholar
  10. 10.
    Bartlett JG. Gorbach SL., Thadepalli H., Finegold SM. Bacteriology of empyema. Lancet 1974; 1:338–40.PubMedCrossRefGoogle Scholar
  11. 11.
    Varkey B., Rose D., Kutty CPK., Politis J. Empyema thoracis during a ten-year period: analysis of 72 cases and comparison to a previous study (1952 to 1967). Arch Intern med 1981; 141: 1771–6.PubMedCrossRefGoogle Scholar
  12. 12.
    Lemmer J., Botham MJ, Orringer MB. Modern management of adult thoracic empyema. J Thorac Cardiovasc Surg 195; 90: 849–55.Google Scholar
  13. 13.
    Ries K., Levison ME., Kaye D. Transtracheal aspiration in pulmonary infection. Arch Intern Med 1974; 133: 453–8.PubMedCrossRefGoogle Scholar
  14. 14.
    Pollock HM., Hawkins EL., Bonner JR., Sparkman T. Bass JB. Jr. Diagnosis of bacterial pulmonary infections with quantitative protected catheter cultures obtained during bronchoscopy. J Clin Microbiol 1983; 17: 255–9.PubMedGoogle Scholar
  15. 15.
    Shapiro MS., Matthay RA. Pulmonary aspiration: keys to effective therapy. Journal of Respiratory Disease 1989; 10: 59–74.Google Scholar
  16. 16.
    Smith DT. Experimental aspiratory abscess. Arch Surg 1927; 14: 231–9.Google Scholar
  17. 17.
    Smith DT. Fuso-spirochaetal disease of the lungs: its bacteriology, pathology and experimental reproduction. American Review of Tuberculosis 1927; 16: 584–98.Google Scholar
  18. 18.
    Mayrand D. Holt SC. Biology of asaccharolytic black-pigmented Bacteroides species. Microbiol Rev 1988; 52: 134–52.PubMedGoogle Scholar
  19. 19.
    Crabb JH. Finberg R., Onderdonk AB., Kasper DL.. T cell regulation of Bacteroides fragilis-induced intraabdominal abscess. Rev Infect Dis 1990; 12(suppl 2): S 178–84.Google Scholar
  20. 20.
    Rotstein OD., Pruett TL., Fiegel VD., Nelson RD., Simmons RL. Suc-clinic acid, a metabolic by-product of Bacteroides species, inhibits polymorphonuclear leukocyte function. Infect Immun 1985; 48: 402–8.PubMedGoogle Scholar
  21. 21.
    Rotstein OD., Vittorini T., Kao J., McBurney MI., Nasmith PE. Grinstein S. A soluble Bacteroides by-product impairs phagocytic killing of Escerichia coli by neutrophils. Infect Immun 1989; 57: 745–53.PubMedGoogle Scholar
  22. 22.
    Eftimiadi C., Tonetti M., Cavallero A., Sacco O., Rossi GA. Short-chain fatty acids produced by anaerobic bacteria inhibit phagocytosis by human lung phagocytes. J Infect Dis 1990; 161: 138–42.PubMedGoogle Scholar
  23. 23.
    Guillemont L., Halle J., Rist E. Recherches bactériologiques et expérimentales sur les pleurésies putrides. Arch Med Exp Pt d’Anat Pathol 1904; 16: 571–640.Google Scholar
  24. 24.
    Brook I., Finegold SM. Bacteriology of aspiration pneumonia in children. Pediatrics 1980; 65: 1115–20.PubMedGoogle Scholar
  25. 25.
    Finegold SM., George WL., Mulligan ME. Anaerobic infections. Dis Mon 1985; 31: Part 1 10: 1–77; part 2 11: 1–97.Google Scholar
  26. 26.
    Lorber B., Swenson RM. Bacteriology of aspiration pneumonia: a prospective study of community-and hospital-acquired cases. Ann Intern Med 1974; 81: 329–31.PubMedGoogle Scholar
  27. 27.
    Johanson Jr WG., Harris GD. Aspiration pneumonia, anaerobic infections and lung abscess. Med Clin North Am 1980: 385–395.Google Scholar
  28. 28.
    Wattel F., Mathieu D., Tonnel AB., Lafitte JJ. Infections pleuropulmonaires à germes anaérobies et oxygénothérapie hyperbare. MEd Sub Hyp 1987; 6: 71–79.Google Scholar
  29. 29.
    Park MK. Effects of hyperbaric oxygen in infections disease: basic mechanisms. In Kindwall EP, whelan HT Eds, Hyperbaric Medicike Practice, Best publishing company, Flagstraff (USA) 1999: 205–243.Google Scholar
  30. 30.
    Bulynin VI., Koshelev PI., Alekseeva LN., Babkin VF. Merkulov AT. Hyperbaric oxygenation in the treatment of patients with suppurative diseases of the lung and pleural. Khirurgiia 1982: 56–9.Google Scholar
  31. 31.
    Lesnitskii LS., Buravtsov VI. Hyperbaric oxygenation in the treatment of patients with acure purulent-dectrictive lung and pleural diseases. Vestn Khir Im I I Grek 1983; 131: 36–42.PubMedGoogle Scholar
  32. 32.
    Lytkin MI., Buravtsov VI. Hyperbaric oxygenation in the treatment of infections destruction of the lungs. Vestn Khir Im I I Grek 1985; 135: 131–6.PubMedGoogle Scholar
  33. 33.
    Buravtsov VI. Effectiveness of HBO in the complex treatment of patients with infectious destructive lung diseases. Vestn Khir Im I I Grek 1989: 142: 118–21.PubMedGoogle Scholar
  34. 34.
    Bulynin VI, Koshelev PI, Barsukov VA. Treatment of acute lung abscess using hyperbaric oxygenation. Grud Serdechnososudistaia Khir 1990: 37–41.Google Scholar
  35. 35.
    Neimark II. Efferent therapy in the complex treatment of pyo-destructive processes in the lungs. Grud Serdechnososudistaia Khir 1990: 71–4.Google Scholar

Copyright information

© Springer 2006

Authors and Affiliations

  • Daniel Mathieu
    • 1
  1. 1.Service d’Urgence Respiratoire, de Réanimation Médicale et de Médecine Hyperbare, Hôpital CalmetteCHRU LILLELILLE CedexFrance

Personalised recommendations